HAEMONETICS CORP - HAE

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Mar 27, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Mar 03, 2026 SCHEDULE 13G North Peak Capital Management, LLC 5.1% 2,370,495 View
Mar 03, 2026 SCHEDULE 13G North Peak Capital GP, LLC 4.0% 1,882,037 View
Mar 03, 2026 SCHEDULE 13G North Peak Capital Partners, LP 0.3% 135,354 View
Mar 03, 2026 SCHEDULE 13G North Peak Capital Partners II, LP 2.1% 993,566 View
Mar 03, 2026 SCHEDULE 13G North Peak Capital Alpha Fund, LP 1.4% 651,061 View
Mar 03, 2026 SCHEDULE 13G North Peak Capital Ultra Fund, LP 0.2% 102,056 View
Mar 03, 2026 SCHEDULE 13G Michael Kevin Kahan 4.0% 1,882,037 View
Mar 03, 2026 SCHEDULE 13G Jeremy Steven Kahan 4.0% 1,882,037 View
Feb 13, 2026 SCHEDULE 13G AQR Capital Management, LLC 6.76% 3,163,104 View
Feb 13, 2026 SCHEDULE 13G AQR Capital Management Holdings, LLC 6.76% 3,163,104 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.